Colgate-Palmolive (India) Business Update
Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 to integrate oral health awareness messages into the show's daily narrative through unique celebrity sign-offs.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
27 announcements with these filters
Colgate-Palmolive (India) has partnered with Kaun Banega Crorepati Season 18 to integrate oral health awareness messages into the show's daily narrative through unique celebrity sign-offs.
Colgate-Palmolive (India) Limited announced the resignation of Mr. G. Ramprasad as its Internal Auditor, effective August 31, 2026, to explore other opportunities.
Colgate-Palmolive (India) reported Q1 sales of Rs. 1591 crores, a 12% increase. Strategy focuses on driving oral care consumption and premiumisation, with premium segments growing 5X faster than competitors.
Colgate-Palmolive (India) announced the resignation of MD & CEO Prabha Narasimhan, effective September 27, 2026. Manish Anandani succeeds her as MD & CEO effective September 28, 2026.
Colgate-Palmolive's PerioGard portfolio became India's first gum care regimen to earn the Indian Society of Periodontology's (ISP) Seal of Acceptance for its clinical standards.
Colgate India reported robust Q1 FY27 net sales growth of 12% YoY, accelerating from 9% in the previous quarter. The company is focused on category growth through premiumization and expanding rural toothbrush penetration.
Colgate-Palmolive (India) held its 85th Annual General Meeting on July 29, 2026. The meeting transacted standard business items as outlined in the notice.
Colgate-Palmolive (India) Ltd reported revenue from operations of ₹1,603 Cr (+11.8% YoY) and net profit of ₹343.1 Cr (+7.0% YoY) for Q1 FY27.
Colgate-Palmolive (India) announced completion of its 2025 sustainability goals and unveiled its 2030 'SMILE' strategy to advance climate action and social impact.
Colgate-Palmolive (India) Limited scheduled a board meeting on July 29, 2026. The board will consider unaudited financial results for the quarter ended June 30, 2026.
Colgate Palmolive (India) filed its BRSR for FY2025-26, detailing ESG and sustainability performance. The report includes stakeholder disclosures and compliance with SEBI regulations.
Colgate Palmolive (India) Ltd. has scheduled its 85th AGM for July 29, 2026. The Annual & ESG Report for FY 2025-26 is also submitted to shareholders.
Gammon India Limited appointed Mr. Ajay Bhatnagar as an Additional Independent Director effective May 30, 2026. This strengthens the board's governance with his extensive infrastructure expertise.
Gammon India Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report notes procedural delays in financial result submissions.
Colgate-Palmolive (India) reported Q4 FY26 net sales growth of 9% (Rs. 1,583 cr) with best-in-class EBITDA margins of 32.2%. Strategy focuses on premiumization, oral care category leadership, and digital/AI-led efficiency.
Colgate-Palmolive India reported audited FY26 results with 9% Q4 sales growth. The Board also declared a second interim dividend of Rs. 24 per share.
Colgate-Palmolive (India) Limited submitted its Annual Secretarial Compliance Report for FY 2025-26. The report confirms the company's full compliance with SEBI listing regulations and secretarial standards.
Colgate-Palmolive India declared an interim dividend of ₹24 per share for FY 2025-26. The record date is June 1, 2026, with payments starting June 17.
Colgate Palmolive (India) approved the re-appointment of Jacob Sebastian Madukkakuzy as Executive Director and CFO. His five-year term commences October 2026, ensuring leadership continuity.
Colgate-Palmolive India reported 9% YoY topline growth for Q4'FY26, focused on oral care premiumization and driving consumption via rural pilots and urban recovery.
Colgate-Palmolive (India) Ltd reported revenue from operations of ₹1,595 Cr (+9.1% YoY) and net profit of ₹353.3 Cr (-0.5% YoY) for Q4 FY26.
Colgate-Palmolive (India) reported a ₹1,325.31 Crore net profit for FY26. The board declared a second interim dividend of ₹24 per share, totaling ₹48 for the year.
Life Insurance Corporation of India acquired 50,000 additional shares in Colgate-Palmolive (India) Ltd. Its total stake increased to 5.003%, crossing the regulatory disclosure threshold.
Colgate-Palmolive (India) Ltd will hold a Board Meeting on May 22, 2026. Directors will consider FY2026 audited results and potential dividend declarations.
Colgate-Palmolive (India) Ltd reported net profit of ₹324 Cr (+0.3% YoY) for Q3 FY26.
Colgate-Palmolive (India) Limited launched a nationwide initiative offering free dental check-ups to improve oral health access across India. In partnership with the Indian Dental Association and Bajaj Health, the program connects consumers with 63,000 dentists via QR codes on packs. This initiative aims to drive a shift toward proactive dental care and early diagnosis.
Colgate-Palmolive (India) Limited submitted its quarterly Confirmation Certificate for the period ended March 31, 2026. Issued by MUFG Intime India Private Limited, the certificate confirms compliance with SEBI regulations regarding the dematerialisation and cancellation of security certificates. This is a routine regulatory filing with no material financial impact.